Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

DiproBio (Shanghai) clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with DiproBio (Shanghai) as lead sponsor. Synced 17 Nov 2026
3Current trials
0Recruiting now
0Drugs in these trials
1Trial register
At a glance

DiproBio (Shanghai) is the lead sponsor of 3 current clinical trials in our China register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Not applicable. The most-studied condition is Allergy.

ClinicalTrials.gov trials by status

  • Not yet open267%
  • Active, closed133%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by DiproBio (Shanghai)

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Effects of Bifidobacterium Longum Subsp. Infantis i18 on Gut Microbiota Development and Health in Early Life
NCT07938476 · ClinicalTrials.gov ↗ · Allergy, Gastrointestinal Symptoms, Gut -Microbiota
Not applicable Not yet open 2026-11 China
Effects of a Combination of Bifidobacterium Longum Subsp. Longum Strains on Stress and Related Health Outcomes in Young Adult
NCT07940283 · ClinicalTrials.gov ↗ · Psychological Stress, Mental Health
Not applicable Not yet open 2026-11 China
National Cohort Study on Infant Gut Microbiota and Nutrition
NCT07705685 · ClinicalTrials.gov ↗ · Fecal Gut Microbiota
Observational Active, closed 2026-04 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in DiproBio (Shanghai) trials

6 conditions
Allergy1Gastrointestinal Symptoms1Gut -Microbiota1Fecal Gut Microbiota1Psychological Stress1Mental Health1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China30

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Allergy

SponsorTrials
DBV Technologies1
Nasus Pharma1

Sponsors with the most current trials registered for this condition.

05

Questions about DiproBio (Shanghai) trials

How many clinical trials does DiproBio (Shanghai) sponsor?

DiproBio (Shanghai) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are DiproBio (Shanghai) trials recruiting?

Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.